Fundraising FoxArk Biosciences
Shanghai, CN · 3 known investors
Find your way into Ark Biosciences
Sign up to see every warm intro you have to Ark Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ark Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.
Investors · 3
Decheng Capitallisted by Decheng CapitalMenlo Park
How we know: Decheng Capital's portfolio page · the VCSheet dataset · Not right? Tell us
YuanBio Venture Capitallisted by YuanBio Venture CapitalSuzhou
How we know: YuanBio Venture Capital's portfolio page · Not right? Tell us
Qiming Venture PartnersreportedBeijing
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Ark Biosciences do?
- Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.
- Who are Ark Biosciences's investors?
- Ark Biosciences's investors include Decheng Capital, YuanBio Venture Capital, Qiming Venture Partners.
- Where is Ark Biosciences headquartered?
- Ark Biosciences is headquartered in Shanghai, CN.